Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €7.70 EUR
Change Today +0.102 / 1.34%
Volume 0.0
AFF On Other Exchanges
As of 1:37 PM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by AFFYMETRIX INC (AFF) in the last 6 months

Announced 08/9/15
Response Genetics, Inc

Response Genetics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on August 9, 2015. The debtor listed its assets of $15.41 million and liabilities $16.16 million. The largest unsecured creditors include Life Technologies Corporation, Abbott Molecular Inc., The Trout Group LLC, Affymetrix Inc., University of Southern California, Willkie Farr & Gallagher LLP, XIFIN, Inc., Blue Cross of California, ...
Read More

AFF's price was unchanged after the transaction was announced on 08/9/15.
Creditor / Lender
Abbott Molecular Inc.
Affymetrix Inc.
Blue Cross of California, Inc.
Flatiron Capital Corp.
Hogan Lovells US LLP
Life Technologies Corporation
The Trout Group LLC
University of Southern California
Willkie Farr & Gallagher LLP
Financial Advisor
Canaccord Genuity Inc.
Legal Advisor
Pachulski Stang Ziehl & Jones LLP
Announced 05/14/15
15.00M for Eureka Genomics Corporation

Affymetrix Inc. (NasdaqGS:AFFX) entered into an agreement to acquire the assets of Eureka Genomics Corporation for $15 million in cash on May 13, 2015. Affymetrix will immediately launch the Eureka Genomics’ technologies as Eureka Genotyping Solution and Services for use in a wide range of routine animal and plant testing applications through an early access program. Sarah K. Solum, Jeffrey C. Lau, Donald K. Lang, Rachel D. Kleinberg, Adam Bedzow, Cynthia Akard, Katie ...
Read More

AFF's price was unchanged after the transaction was announced on 05/14/15.
Investor / Buyer
Affymetrix Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFF:GR €7.70 EUR +0.102

AFF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Foundation Medicine Inc $19.97 USD +0.38
Luminex Corp $18.16 USD +0.26
Pacific Biosciences of California Inc $8.07 USD +0.56
Sequenom Inc $2.11 USD +0.01
Takara Bio Inc ¥1,230 JPY +53.00
View Industry Companies

Industry Analysis


Industry Average

Valuation AFF Industry Range
Price/Earnings 39.7x
Price/Sales 1.9x
Price/Book 2.1x
Price/Cash Flow 36.9x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMETRIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at